Component

Strontium-associated DXA bone-density overestimation

Context-specific entity; species, compartment and exposure are stated on each claim.

3 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. Theoretical attenuation calculations predicted strontium overestimation factors around 9–10.8 for the tested DXA systems, with different factors for single-energy CT.

    Experimental context and source evidence
    availability_state
    biomarker_context Imported condition classification; unverified.
    evidence_access
    Primary abstract
    experimental_model
    Physical modeling using X-ray attenuation coefficients.
    limitations
    Historical device calculations, not universal current scanner calibration; bone retention also matters after treatment stops.
    nutrient_topic
    Strontium collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Strontium
    plain_language
    The size of the measurement effect depends partly on the method.
    primary_references
    Effect of bone strontium on BMD measurements. · 2007 · https://pubmed.ncbi.nlm.nih.gov/17289524/ · DOI 10.1016/j.jocd.2006.10.004
    trigger_kind
    biomarker_context Imported condition classification; unverified.

    Strontium: calcium interactions, cellular mechanisms and mineralization (2026-09-19) · lines 318–324

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Physical modeling using X-ray attenuation coefficients. · source_derived_draft · unverified_draft

    ## strontium-dxa-device-dependence The size of the measurement effect depends partly on the method. Theoretical attenuation calculations predicted strontium overestimation factors around 9–10.8 for the tested DXA systems, with different factors for single-energy CT. Model: Physical modeling using X-ray attenuation coefficients. Limitations: Historical device calculations, not universal current scanner calibration; bone retention also matters after treatment stops. Evidence access: Primary abstract Effect of bone strontium on BMD measurements. · 2007 · https://pubmed.ncbi.nlm.nih.gov/17289524/ · DOI 10.1016/j.jocd.2006.10.004
    Complete structured claim and evidence
  2. In calcium/strontium hydroxyapatite mixtures, approximately 1 mol% strontium caused about 10% overestimation of DXA bone mineral density/content across the tested instruments.

    Experimental context and source evidence
    availability_state
    biomarker_context Imported condition classification; unverified.
    evidence_access
    Primary abstract
    experimental_model
    Physical phantom experiments with 0–3.5 mol% strontium.
    limitations
    Mixture calibration is not a patient-specific correction; bone strontium content at the scanned site is required.
    nutrient_topic
    Strontium collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Strontium
    plain_language
    Strontium can make a scan read denser without an equivalent increase in calcium mineral.
    primary_references
    Influence of strontium on bone mineral density and bone mineral content measurements by dual X-ray absorptiometry. · 1999 · https://pubmed.ncbi.nlm.nih.gov/10677790/ · DOI 10.1016/s1094-6950(06)60402-2
    trigger_kind
    biomarker_context Imported condition classification; unverified.

    Strontium: calcium interactions, cellular mechanisms and mineralization (2026-09-19) · lines 310–316

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Physical phantom experiments with 0–3.5 mol% strontium. · source_derived_draft · unverified_draft

    ## strontium-dxa-physics Strontium can make a scan read denser without an equivalent increase in calcium mineral. In calcium/strontium hydroxyapatite mixtures, approximately 1 mol% strontium caused about 10% overestimation of DXA bone mineral density/content across the tested instruments. Model: Physical phantom experiments with 0–3.5 mol% strontium. Limitations: Mixture calibration is not a patient-specific correction; bone strontium content at the scanned site is required. Evidence access: Primary abstract Influence of strontium on bone mineral density and bone mineral content measurements by dual X-ray absorptiometry. · 1999 · https://pubmed.ncbi.nlm.nih.gov/10677790/ · DOI 10.1016/s1094-6950(06)60402-2
    Complete structured claim and evidence

Where it participates (unsigned role)

  1. SOTI reported BMD increases of 14.4% at the lumbar spine and 8.3% at the femoral neck by month 36.

    Strontium ranelate → DXA BMD in the SOTI trial source_derived_draftungraded
    Experimental context and source evidence
    availability_state
    biomarker_context Imported condition classification; unverified.
    evidence_access
    Primary abstract
    experimental_model
    Same randomized trial; repeated densitometry.
    limitations
    Do not equate the full BMD increase with new calcium bone mass; independent strontium attenuation studies establish measurement inflation.
    nutrient_topic
    Strontium collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Strontium
    plain_language
    The reported scan changes include a composition-sensitive measurement.
    primary_references
    The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. · 2004 · https://pubmed.ncbi.nlm.nih.gov/14749454/ · DOI 10.1056/NEJMoa022436
    trigger_kind
    biomarker_context Imported condition classification; unverified.

    Strontium: calcium interactions, cellular mechanisms and mineralization (2026-09-19) · lines 430–436

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Same randomized trial; repeated densitometry. · source_derived_draft · unverified_draft

    ## strontium-soti-bmd The reported scan changes include a composition-sensitive measurement. SOTI reported BMD increases of 14.4% at the lumbar spine and 8.3% at the femoral neck by month 36. Model: Same randomized trial; repeated densitometry. Limitations: Do not equate the full BMD increase with new calcium bone mass; independent strontium attenuation studies establish measurement inflation. Evidence access: Primary abstract The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. · 2004 · https://pubmed.ncbi.nlm.nih.gov/14749454/ · DOI 10.1056/NEJMoa022436
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards